Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma

Rockville, Maryland, UNITED STATES


Haichang to fund development through completion of Phase IIa Proof-of-Concept Clinical Trial